ChemBriefMylan to sell up to $363 million stake in India's Biocon, term sheet shows
Mylan Inc plans to sell up to 92 million shares in Indian drugmaker Biocon Ltd, valued at up to $363 million, according to a term sheet reviewed by Reuters.
reuters · 2026-07-13 06:19